Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received August 9, 2021
- Accepted January 17, 2023
- Published online January 25, 2023.
Article Versions
- You are currently viewing a previous version of this article (January 25, 2023 - 06:55).
- View the most recent version of this article
Copyright & Usage
Copyright © 2023, Parenteral Drug Association
Author Information
- Sven Deutschmann1,
- Mousumi Paul2,
- Marja Claassen-Willemse3,
- Jonas van den Berg4,
- Pieta IJzerman-Boon3,
- Viviane Grunert da Fonseca1,
- Ellen Brunbech5,
- Lynn Johnson6,
- Chris Knutsen7,
- Lucile Plourde8,
- Joanny Salvas9,
- Philip Villari2,
- Lisa Wysocki10 and
- Margit Franz-Riethdorf11,12 (margit.franz-riethdorf{at}biophorum.com)
- 1 Roche Diagnostics GmbH, Penzberg, Germany;
- 2 Merck & Co., Inc., Kenilworth, NJ, USA;
- 3 MSD, Oss, The Netherlands;
- 4 Roche Diagnostics GmbH, Mannheim, Germany;
- 5 Novo Nordisk A/S, Bagsvaerd, Denmark;
- 6 Takeda, Lexington, MA, USA;
- 7 Bristol-Myers Squibb, New Brunswick, NJ, USA;
- 8 Sanofi Pasteur, Marcy-l Etoile, France;
- 9 Pfizer, Kirkland, QC, Canada;
- 10 GlaxoSmithKline, Collegeville, PA, USA;
- 11 BioPhorum Operations Group Limited, 5 Westbrook Court, Sharrowvale Road, Sheffield, S11 8YZ, UK
- ↵* Corresponding author; email: margit.franz-riethdorf{at}biophorum.com